Seagen to Report Second Quarter 2023 Financial Results on August 2, 2023

Rhea-AI Summary

Seagen Inc. (Nasdaq: SGEN) to Report Q2 2023 Financial Results, No Conference Call Due to Pfizer Acquisition

BOTHELL, Wash.--(BUSINESS WIRE)-- Seagen Inc. (Nasdaq: SGEN) today announced that it will report its second quarter 2023 financial results on Wednesday, August 2, 2023.

Given the previously announced agreement to be acquired by Pfizer Inc., Seagen will not be hosting a conference call.

About Seagen

Founded 25 years ago, Seagen Inc. is a global biotechnology company that discovers, develops, manufactures and commercializes targeted cancer therapeutics, with antibody-drug conjugates (ADCs) at our core. Our colleagues work together with urgency to improve and extend the lives of people living with cancer. An ADC technology trailblazer, approximately one-third of FDA-approved and marketed ADCs use Seagen technology. Seagen is headquartered in Bothell, Washington and has locations in California, Canada, Switzerland and across Europe. For additional information, visit www.seagen.com and follow us on Twitter and LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230712159152/en/

For Investors

Douglas Maffei, Ph.D.

Vice President, Investor Relations

(425) 527-4881

dmaffei@seagen.com

For Media

David Caouette

Vice President, Corporate Communications

(310) 430-3476

dcaouette@seagen.com

Source: Seagen Inc.

FAQ

What is Seagen Inc. (Nasdaq: SGEN) announcing?

Seagen will report its second quarter 2023 financial results on August 2, 2023.

Why is Seagen not hosting a conference call?

Seagen will not host a conference call due to the previously announced agreement to be acquired by Pfizer Inc.

What is the ticker symbol for Seagen Inc.?

The ticker symbol for Seagen Inc. is SGEN.